Drugmakers Find a Salve That Nullifies Trump Tariffs: Prognosis

Hello, everyone, it’s Damian in New York. A White House crackdown on drug prices was, counterintuitively, warmly received by pharmaceutical investors. I’ll explain why, but first ...

Today’s must-reads

• EU antitrust regulators raided Sanofi offices over “disparagement.”
• Permira is weighing a sale of Neuraxpharm that could bring more than €3 billion.
• Opinion: Chinese drugmakers have reasons to fear Washington.

Crisis averted

President Donald Trump was pleased. Standing before a gaggle of reporters in the Oval Office on Tuesday, he explained that after years of twisting arms and cajoling pharmaceutical executives, he was finally lowering drug costs and “ending the era ...